These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
376 related articles for article (PubMed ID: 26464423)
1. Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia. Tseng YC; Kulp SK; Lai IL; Hsu EC; He WA; Frankhouser DE; Yan PS; Mo X; Bloomston M; Lesinski GB; Marcucci G; Guttridge DC; Bekaii-Saab T; Chen CS J Natl Cancer Inst; 2015 Dec; 107(12):djv274. PubMed ID: 26464423 [TBL] [Abstract][Full Text] [Related]
2. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia. Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162 [TBL] [Abstract][Full Text] [Related]
3. Cryptotanshinone prevents muscle wasting in CT26-induced cancer cachexia through inhibiting STAT3 signaling pathway. Chen L; Yang Q; Zhang H; Wan L; Xin B; Cao Y; Zhang J; Guo C J Ethnopharmacol; 2020 Oct; 260():113066. PubMed ID: 32505837 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy. Reed SA; Sandesara PB; Senf SM; Judge AR FASEB J; 2012 Mar; 26(3):987-1000. PubMed ID: 22102632 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia. Silva KA; Dong J; Dong Y; Dong Y; Schor N; Tweardy DJ; Zhang L; Mitch WE J Biol Chem; 2015 Apr; 290(17):11177-87. PubMed ID: 25787076 [TBL] [Abstract][Full Text] [Related]
6. Ghrelin improves body weight loss and skeletal muscle catabolism associated with angiotensin II-induced cachexia in mice. Sugiyama M; Yamaki A; Furuya M; Inomata N; Minamitake Y; Ohsuye K; Kangawa K Regul Pept; 2012 Oct; 178(1-3):21-8. PubMed ID: 22750276 [TBL] [Abstract][Full Text] [Related]
8. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study. Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the anticatabolic effects of leucine and Ca-β-hydroxy-β-methylbutyrate in experimental models of cancer cachexia. Mirza KA; Pereira SL; Voss AC; Tisdale MJ Nutrition; 2014; 30(7-8):807-13. PubMed ID: 24984997 [TBL] [Abstract][Full Text] [Related]
10. Rosiglitazone and imidapril alone or in combination alleviate muscle and adipose depletion in a murine cancer cachexia model. Chen SZ; Xiao JD Tumour Biol; 2014 Jan; 35(1):323-32. PubMed ID: 23959470 [TBL] [Abstract][Full Text] [Related]
11. Influence of divergent exercise contraction mode and whey protein supplementation on atrogin-1, MuRF1, and FOXO1/3A in human skeletal muscle. Stefanetti RJ; Lamon S; Rahbek SK; Farup J; Zacharewicz E; Wallace MA; Vendelbo MH; Russell AP; Vissing K J Appl Physiol (1985); 2014 Jun; 116(11):1491-502. PubMed ID: 24458747 [TBL] [Abstract][Full Text] [Related]
12. Epigallocatechin-3-gallate effectively attenuates skeletal muscle atrophy caused by cancer cachexia. Wang H; Lai YJ; Chan YL; Li TL; Wu CJ Cancer Lett; 2011 Jun; 305(1):40-9. PubMed ID: 21397390 [TBL] [Abstract][Full Text] [Related]
13. Cancer Cachexia: Emerging pre-clinical evidence and the pathway forward to clinical trials. Martin L; Sawyer MB J Natl Cancer Inst; 2015 Dec; 107(12):djv322. PubMed ID: 26453482 [No Abstract] [Full Text] [Related]
14. C/EBPβ mediates tumour-induced ubiquitin ligase atrogin1/MAFbx upregulation and muscle wasting. Zhang G; Jin B; Li YP EMBO J; 2011 Aug; 30(20):4323-35. PubMed ID: 21847090 [TBL] [Abstract][Full Text] [Related]
15. Selumetinib Attenuates Skeletal Muscle Wasting in Murine Cachexia Model through ERK Inhibition and AKT Activation. Quan-Jun Y; Yan H; Yong-Long H; Li-Li W; Jie L; Jin-Lu H; Jin L; Peng-Guo C; Run G; Cheng G Mol Cancer Ther; 2017 Feb; 16(2):334-343. PubMed ID: 27599525 [TBL] [Abstract][Full Text] [Related]
16. IGF-1 is downregulated in experimental cancer cachexia. Costelli P; Muscaritoli M; Bossola M; Penna F; Reffo P; Bonetto A; Busquets S; Bonelli G; Lopez-Soriano FJ; Doglietto GB; Argilés JM; Baccino FM; Rossi Fanelli F Am J Physiol Regul Integr Comp Physiol; 2006 Sep; 291(3):R674-83. PubMed ID: 16614058 [TBL] [Abstract][Full Text] [Related]
17. Excessive glucocorticoid-induced muscle MuRF1 overexpression is independent of Akt/FoXO1 pathway. Wang XJ; Xiao JJ; Liu L; Jiao HC; Lin H Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29046370 [TBL] [Abstract][Full Text] [Related]
18. Citrus unshiu peel extract alleviates cancer-induced weight loss in mice bearing CT-26 adenocarcinoma. Kim A; Im M; Gu MJ; Ma JY Sci Rep; 2016 Apr; 6():24214. PubMed ID: 27064118 [TBL] [Abstract][Full Text] [Related]
19. Ghrelin inhibits skeletal muscle protein breakdown in rats with thermal injury through normalizing elevated expression of E3 ubiquitin ligases MuRF1 and MAFbx. Balasubramaniam A; Joshi R; Su C; Friend LA; Sheriff S; Kagan RJ; James JH Am J Physiol Regul Integr Comp Physiol; 2009 Apr; 296(4):R893-901. PubMed ID: 19211729 [TBL] [Abstract][Full Text] [Related]
20. Ghrelin relieves cancer cachexia associated with the development of lung adenocarcinoma in mice. Tsubouchi H; Yanagi S; Miura A; Matsumoto N; Kangawa K; Nakazato M Eur J Pharmacol; 2014 Nov; 743():1-10. PubMed ID: 25257464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]